This inventor holds 1 USPTO granted patent and 10 published patent applications. Top assignee: Bright Peak Therapeutics Ag. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Arnaud Goepfert: Innovator in Immunocytokine Research
Introduction
Arnaud Goepfert is a notable inventor based in Sierentz, France. He has made significant contributions to the field of immunocytokines, particularly through his innovative research and patenting efforts. His work focuses on enhancing immune responses through targeted therapies.
Latest Patents
Arnaud Goepfert holds a patent for "Immune antigen specific IL-18 immunocytokines and uses thereof." This patent describes modified immunocytokine compositions that include antibodies or antigen-binding fragments specific for immune cell antigens and IL-18 polypeptides. The patent also outlines methods of treatment and manufacturing processes for these immunocytokine compositions. He has 1 patent to his name.
Career Highlights
Arnaud Goepfert is associated with Bright Peak Therapeutics AG, where he applies his expertise in immunology and biotechnology. His role at the company allows him to work on cutting-edge therapies aimed at improving patient outcomes through innovative treatments.
Collaborations
Arnaud collaborates with Vijaya Raghavan Pattabiraman, contributing to advancements in their shared field of research. Their partnership exemplifies the collaborative spirit often found in scientific innovation.
Conclusion
Arnaud Goepfert's work in immunocytokine research highlights his commitment to advancing medical science. His innovative approaches and patented technologies are paving the way for new therapeutic options in immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile